- Country: Germany
- Summary: Open-House Biologika Discount Contracts 2024-03-Omalizumab
- DET Ref No: 127424696
- Deadline: 31 Oct 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 645643-2025
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- The funds involved pursue the goal of concluding discount contracts according to Section 130a (8) SGB V with all suitable pharmaceutical entrepreneurs to the active ingredient omalizumab. Contract content is not guided, uniform conditions apply. Exclusivity too. independent from the date of the conclusion of the contract. Further information can be found in the participation and contract documents.
the Completion of pharmaceutical discounts according to Section 130a (8) SGB V on the active ingredient omalizumab as part of an open house procedure.
supplies - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINOpen-House Biologika Discount Contracts 2024-03-Omalizumab - Germany Tender
The TECHNICIANS' HEALTH INSURANCE, a Government sector organization in Germany, has announced a new tender for Open-House Biologika Discount Contracts 2024-03-Omalizumab. This tender is published on GermanyTenders under DET Ref No: 127424696 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-10-31.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
